Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants And Warfarin for Stroke Prevention In Atrial Fibrillation In Venezuela
Abstract
Authors
Y Fernández Ávila KC Garcia S Garrido Lecca BM Donato A Juarez-Garcia